Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Hepatocellular 13Liver Neoplasms 3Carcinoma, Renal Cell 3Glioblastoma 2Refractory Solid Tumors 1Recurrence 1Prostatic Neoplasms 1Pediatric Solid Tumors 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Liver Diseases 1Gliosarcoma 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Medullary 1Brain Neoplasms 1Advanced Cancers 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Paclitaxel 6Radiotherapy 5Carboplatin 5capmatinib 2Radiosurgery 2Gemcitabine 2tetrathiomolybdate 1spartalizumab 1pembrolizumab 1palbociclib 1onartuzumab 1nintedanib 1fludarabine phosphate 1fludarabine 1efaproxiral 1durvalumab 1binimetinib 1aldesleukin 1Vinorelbine 1Technetium Tc 99m Sestamibi 1Taxes 1Sorafenib 1Platinum 1Nivolumab 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Interleukin-2 1Immunotherapy 1Immunoenzyme Techniques 1Gefitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Adenocarcinoma of Lung × Sorafenib × Clear all
NCT00547443 2019-01-10

Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

University of Texas Southwestern Medical Center

Phase 1/2 Withdrawn
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡